RxDoctor Payments Data

Joseph Follis

Nurse Practitioner · Bolivar, MONPI 1780666214

Payments from drug & device makers

$3,124in general payments, 2019–2025

Across 171 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$524
  • AbbVie$421
  • Lilly USA, LLC$343
  • AstraZeneca$248
  • GSK$227
  • Eisai Inc.$182
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$3,124100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,124 in reported general payments places this provider in the 85th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban73$72,991
FarxigaDapagliflozin Propanediol47$47,071
JanuviaSitagliptin Phosphate40$36,370
TrulicityDulaglutide32$31,130
JardianceEmpagliflozin15$25,178
MounjaroTirzepatide17$22,249
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$18,500
OzempicSemaglutide16$13,370
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$12,869
Breo ElliptaFluticasone/Vilanterol18$7,886
Spiriva HandihalerTiotropium Bromide14$7,036
RestasisCyclosporine11$6,679
NexiumEsomeprazole Magnesium12$6,354
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$5,485
Advair HfaFluticasone Propion/Salmeterol16$5,179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$99$72,99173 claims
AstraZenecaFarxiga, Breztri Aerosphere, Nexium$248$66,29473 claims
Lilly USA, LLCTrulicity, Mounjaro$343$53,37949 claims
MerckJanuvia$63$36,37040 claims
GSKTrelegy Ellipta, Breo Ellipta$227$26,38643 claims
Novo NordiskOzempic$524$13,37016 claims
AbbVieRestasis$421$6,67911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Bolivar

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →